Founder of Blueprint. I help companies stop sending emails nobody wants to read.
The problem with outbound isn't the message. It's the list. When you know WHO to target and WHY they need you right now, the message writes itself.
I built this system using government databases, public records, and 25 million job posts to find pain signals most companies miss. Predictable Revenue is dead. Data-driven intelligence is what works now.
Your GTM team is buying lists from ZoomInfo, adding "personalization" like mentioning a LinkedIn post, then blasting generic messages about features. Here's what it actually looks like:
The Typical Guardant Health SDR Email:
Why this fails: The prospect is an expert. They've seen this template 1,000 times. There's zero indication you understand their specific situation. Delete.
Blueprint flips the approach. Instead of interrupting prospects with pitches, you deliver insights so valuable they'd pay consulting fees to receive them.
Stop: "I see you're hiring compliance people" (job postings - everyone sees this)
Start: "Your ACO's colorectal cancer mortality rate is 18% above the CMS benchmark" (Medicare Shared Savings Program data with specific performance metrics)
PQS (Pain-Qualified Segment): Reflect their exact situation with such specificity they think "how did you know?" Use government data with dates, record numbers, facility addresses.
PVP (Permissionless Value Proposition): Deliver immediate value they can use today - analysis already done, deadlines already pulled, patterns already identified - whether they buy or not.
These messages demonstrate such precise understanding of the prospect's current situation that they feel genuinely seen. Every claim traces to a specific government database with verifiable record numbers.
Target CoC-accredited cancer centers in counties with colorectal screening rates 9+ points below state average. These facilities see high volumes of late-stage colorectal cases because their population isn't getting screened.
You're presenting specific county-level data the prospect can verify instantly via PLACES dataset. The 9-point gap and annual case volume prove you researched their facility specifically. The routing question is easy to answer and acknowledges they may already have a strategy in place.
Target ACO-participating hospital systems where cancer mortality rates trail peer benchmarks despite shared savings participation. These systems face financial penalties for underperformance on quality metrics.
The mortality gap and financial impact ($340K) are concrete and verifiable in CMS reports. This ties directly to the CMO's compensation and budget responsibilities. The message is blunt about underperformance but it's factual, not accusatory.
Target ACOs where colorectal cancer survival rates are 12+ percentage points below peer benchmarks and colorectal accounts for 20%+ of cancer volume. This is their largest quality gap.
Uses specific CMS data the prospect can verify. Identifies the cancer type and volume impact. The question assumes they might NOT be analyzing this, which is often true. Survival rate gaps tie directly to performance metrics.
Target cancer centers where primary service area screening rates are 9+ points below statewide average. Translate percentage gap into actual unscreened population count within facility radius.
Geographic specificity shows real analysis. Translating percentage into actual unscreened population count (4,200 adults) makes it concrete. The question is about strategy, not accusatory. Directly relevant to cancer detection KPIs.
Target ACOs where lung cancer mortality rates are 20%+ above peer benchmark ACOs with similar demographics. Focus on systems where lung accounts for 30%+ of total cancer volume.
Specific mortality gap with peer comparison. Volume percentage shows research depth. Focuses on treatment pathways, not just screening. Question is appropriately focused on process ownership.
Target rural CoC-accredited cancer centers in counties with screening rates 14+ points below state average where facility is only comprehensive cancer care provider within 40 miles.
Specific county and gap data. Geographic context (only facility in 40 miles) shows market understanding. Primary care coordination question is strategic, not just operational. Screening is a known pain point in rural areas.
Target ACOs where breast cancer screening rates are 11+ points below benchmark, impacting 800+ eligible women. Calculate financial impact on quality-based shared savings.
Specific screening metric with financial translation. Patient volume (890 women) makes it concrete. Financial impact directly tied to compensation/budget. Clear accountability question.
Target cancer centers where primary service area screening rates are 11+ points below statewide average and facility sees 400+ new colorectal cases annually.
Clear gap quantification. Annual case volume shows research. Connects screening to earlier detection (clinical goal). Leadership question is appropriately strategic.
Target ACOs where cancer screening and outcomes metrics are tracking 15%+ below benchmark through Q3, putting them at risk for quality penalty instead of shared savings in 2025.
Time-bound (Q3 2024, 2025 contract) shows current analysis. Financial swing ($520K) is attention-getting. Penalty vs savings framing is high-stakes. Forward-looking question about strategy.
Target cancer centers where 68%+ of colorectal cases present at Stage III-IV versus 52% statewide average. This 16-point gap suggests screening infrastructure isn't reaching their patient population.
Stage-specific data is exactly what CMOs track. Statewide comparison provides context. Connects late presentation to screening infrastructure. Partnership question is strategic and actionable.
These messages provide actionable intelligence before asking for anything. The prospect can use this value today whether they respond or not.
Pull ACO's cancer quality metrics against CMS benchmarks and identify 3 specific screening/treatment gaps costing shared savings. Show which patient cohorts drive underperformance and estimated financial impact.
Promises specific analysis they don't have. Ties directly to financial metrics (shared savings). Low-commitment ask to receive the analysis. Cohort-level specificity would be valuable.
Map the 4,200 adults age 45+ in facility service area who are unscreened for colorectal cancer by ZIP code and insurance status. Show which ZIPs have highest concentration and which payers cover them.
Specific actionable data (4,200 adults, by ZIP and insurance). Directly supports screening outreach planning. Easy yes/no question. Insurance status mapping is valuable for targeting. Could act on this immediately to plan outreach.
Analyze ACO's colorectal cancer patient flow from screening through treatment and identify where patients are falling through the cracks. Show 3 specific process gaps causing the 18% mortality benchmark miss.
Process-focused, not just outcome-focused. Specific number of gaps identified. "Patient flow" analysis is exactly what CMOs need. Low-commitment ask. But lacks specificity about what the gaps actually are.
Build a screening program framework for Davidson County targeting the 4,200 unscreened adults in facility service area. Include ZIP-code targeting, payer mix, and estimated reach by outreach channel.
Specific to their geography and population. "Framework" implies actionable structure. Includes practical implementation details (channels, payers). Could use this to build a business case internally. Very low barrier to say yes.
Identify the 5 specific interventions that would close ACO's cancer quality gap fastest based on current benchmark position. Each includes patient cohort, estimated impact, and implementation complexity.
Action-oriented (interventions, not just analysis). Prioritization is valuable - CMOs don't have time for everything. Implementation complexity shows practical thinking. Specific number (5 interventions) is concrete. Could present this to leadership.
Build a contact-ready list of 4,200 adults age 45+ in facility service area overdue for colorectal screening, segmented by ZIP and insurance. Include mailing addresses and insurance type for targeted outreach by payer.
If real, this is extremely actionable. Insurance segmentation is valuable for targeted campaigns. But "contact-ready list" with mailing addresses might be overpromising unless addresses are truly available from public data. Feels a bit too good to be true - buyer may be skeptical.
Old way: Spray generic messages at job titles. Hope someone replies.
New way: Use public data to find companies in specific painful situations. Then mirror that situation back to them with evidence.
Why this works: When you lead with "Your ACO's colorectal cancer mortality rate is 18% above the CMS benchmark" instead of "I see you're hiring for oncology roles," you're not another sales email. You're the person who did the homework.
The messages above aren't templates. They're examples of what happens when you combine real data sources with specific situations. Your team can replicate this using the data recipes in each play.
Every play traces back to verifiable public data. Here are the sources used in this playbook:
| Source | Key Fields | Used For |
|---|---|---|
| CDC PLACES | cancer_screening_prevalence, colorectal_cancer_screening_rate, breast_cancer_screening_rate, county, census_tract, zip_code_tabulation_area | Low-Screening-Adherence Regions with CoC-Accredited Facilities |
| Commission on Cancer Hospital Locator | facility_name, location, cancer_services_offered, accreditation_status, zip_code, distance_radius | Low-Screening-Adherence Regions with CoC-Accredited Facilities |
| Medicare Shared Savings Program Data | aco_name, aco_participants, beneficiary_count, performance_data, shared_savings_amount, quality_metrics, service_area | ACO-Participating Systems with Below-Benchmark Cancer Outcomes |
| NCDB Public Benchmark Reports | facility_type, treatment_patterns, survival_outcomes, stage_at_diagnosis, tumor_histology, surgical_resection_type, state_geography, patient_demographics | ACO-Participating Systems with Below-Benchmark Cancer Outcomes |
| Census Bureau ACS Health Insurance Data | insurance_type, age_group, zip_code | Screening Program Design and Outreach Planning |